Follow
Lana Kattan
Lana Kattan
College of Pharmacy, Qatar University
No verified email
Title
Cited by
Cited by
Year
Cardiovascular toxicity profile of doxorubicin: data mining of the FDA adverse event reporting system (FAERS)
L Kattan, E Cerbito, H Dhulkifle, H Korashy, Z Maayah
Cardiovascular Research 120 (Supplement_1), cvae088. 069, 2024
2024
Pharmacy Students’ Perception of the Content and Delivery of Drug Information Training: A Mixed-Methods Study
L Kattan, T Promi, H ElGeed, FN Hussain, A Awaisu, KB Yusuff
American Journal of Pharmaceutical Education 88 (4), 100690, 2024
2024
QCARxE: Qatar-based cardiovascular risk assessment using the English/Arabic version of the EPI· RxISK™ mobile application
LA Kattan
Jordan Journal of Pharmaceutical Sciences 16 (2), 477-477, 2023
2023
QCARxE: Qatar-Based Cardiovascular Risk Assessment Using the English/Arabic Version of the EPI· RxISKTM Mobile Application
DN Mustafa, L Kattan, T Hejazi, A Elhakim, S Aboelbaha, S Homs, ...
Al-Quds University-Deanship of Scientific Research, 2023
2023
Translating and piloting a cardiovascular risk assessment and management online tool using mobile technology
M Zolezzi, A Elhakim, T Hejazi, L Kattan, D Mustafa, S Aboelbaha, ...
Saudi Pharmaceutical Journal 31 (4), 492-498, 2023
2023
Translating and piloting a cardiovascular risk assessment and management online tool using mobile technology
Z Monica, A Elhakim, T Hejazi, L Kattan, D Mustafa, S Aboelbaha, S Homs, ...
Elsevier, 2023
2023
Evaluation of a Mobile Application Tool to Assist Health Care Providers in Cardiovascular Risk Assessment and Management
TA Hejazi, DN Mustafa, L Kattan, M Zolezzi, SA Aboelbaha, S Homs, ...
Qatar University Press, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7